Based on these metrics, I would recommend a HOLD on CIPLA. The recent short-term returns (6M and 3M) are positive, indicating a potential trend reversal, but the Sharpe Ratio suggests that the returns are not excessively risky, warranting a cautious hold rather than a buy or sell.